PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.94%
Revenue growth above 1.5x TSM's 8.77%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
16.15%
Gross profit growth similar to TSM's 15.47%. Walter Schloss would assume both firms track common industry trends.
24.95%
EBIT growth 1.25-1.5x TSM's 17.13%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
24.95%
Operating income growth 1.25-1.5x TSM's 17.13%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
24.16%
Net income growth 1.25-1.5x TSM's 16.92%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
23.38%
EPS growth 1.25-1.5x TSM's 16.88%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
23.68%
Diluted EPS growth 1.25-1.5x TSM's 16.88%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.36%
Slight or no buybacks while TSM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.16%
Slight or no buyback while TSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.65%
Dividend growth above 1.5x TSM's 0.00%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
43.12%
Positive OCF growth while TSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
58.57%
FCF growth above 1.5x TSM's 7.72%. David Dodd would verify if the firm’s strategic investments yield superior returns.
517.62%
10Y revenue/share CAGR above 1.5x TSM's 317.25%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
290.42%
5Y revenue/share CAGR above 1.5x TSM's 149.83%. David Dodd would look for consistent product or market expansions fueling outperformance.
102.92%
3Y revenue/share CAGR at 75-90% of TSM's 121.60%. Bill Ackman would expect new product strategies to close the gap.
3054.94%
10Y OCF/share CAGR above 1.5x TSM's 384.10%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1148.88%
5Y OCF/share CAGR above 1.5x TSM's 227.72%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
186.10%
3Y OCF/share CAGR similar to TSM's 187.76%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
1411.18%
Net income/share CAGR above 1.5x TSM's 466.28% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
703.97%
5Y net income/share CAGR above 1.5x TSM's 257.68%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
110.00%
Below 50% of TSM's 255.04%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
453.02%
10Y equity/share CAGR above 1.5x TSM's 297.72%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
304.44%
5Y equity/share CAGR above 1.5x TSM's 86.07%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
134.17%
3Y equity/share CAGR above 1.5x TSM's 60.67%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
38.19%
Dividend/share CAGR of 38.19% while TSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
7.02%
3Y dividend/share CAGR of 7.02% while TSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
18.58%
AR growth well above TSM's 4.05%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.12%
Inventory growth well above TSM's 8.65%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
25.50%
Asset growth above 1.5x TSM's 8.85%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
12.23%
BV/share growth above 1.5x TSM's 8.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
63.60%
Debt growth far above TSM's 12.14%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
7.98%
R&D growth drastically higher vs. TSM's 9.99%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.15%
SG&A declining or stable vs. TSM's 9.26%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.